Navigation Links
Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C
Date:8/19/2009

atients who have failed to respond to previous therapy.

Important Safety Information About PEGASYS

PEGASYS, alone or in combination with COPEGUS, is indicated for the treatment of adults with chronic hepatitis C virus infection who have compensated liver disease and have not been previously treated with interferon alpha. Patients in whom efficacy was demonstrated included patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A).

Alpha interferons, including PEGASYS, may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Therapy should be withdrawn in patients with persistently severe or worsening signs or symptoms of these conditions. In many, but not all cases, these disorders resolve after stopping PEGASYS therapy (see CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS in complete product information).

Use with Ribavirin. Ribavirin, including COPEGUS, may cause birth defects and/or death of the fetus. Extreme care must be taken to avoid pregnancy in female patients and in female partners of male patients. Ribavirin causes hemolytic anemia. The anemia associated with ribavirin therapy may result in a worsening of cardiac disease. Ribavirin is genotoxic and mutagenic and should be considered a potential carcinogen (see CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS in complete product information).

PEGASYS is contraindicated in patients with hypersensitivity to PEGASYS or any of its components, autoimmune hepatitis, and hepatic decompensation (Child-Pugh score greater than 6; class B and C) in cirrhotic CHC monoinfected patients before or during treatment. PEGASYS is also contraindicated in hepatic decompensation with Child-Pugh score greater than or eq
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Rochester Medical Reports Third Quarter Results
2. Roche Cardiac 200 Offers Rapid Cardiac Diagnostics for the Point of Care
3. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
4. Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
5. Roche Diabetes Care Announces Unique Coaching Program for Diabetes Educators as Part of Long-Term Commitment to Fight the Disease
6. NJLRA Statement in Response to Roches Discontinuation of Accutane(R)
7. Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
8. Purple Communications Dream Bigger Initiative Honors Rochester Physician and Deaf Community Trailblazer
9. Rochester Medical Corporation Set to Join Russell 3000 Index
10. Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
11. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
(Date:12/25/2014)... 2014 BambooFlooringChina.com sells many bamboo products ... flooring. Today, the company announces big discounts on ... and colors. , BambooFlooringChina.com is the world’s leader in ... is valid until Jan. 20, 2015. , The bamboo ... with a natural thread. All the bamboo strips for ...
(Date:12/25/2014)... December 25, 2014 When head lice hits ... in a frenzy to get rid of it while keeping ... in Coral Gables now have the solution right in their ... clinic location, Lice Troopers provides full spectrum head lice screening ... Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, ...
(Date:12/25/2014)... By Dennis Thompson ... -- Very sick children with complex chronic illnesses can receive ... a "medical home," with easy access to a team of ... were less likely to become seriously ill and need either ... received treatment at an enhanced medical home clinic at the ...
(Date:12/25/2014)... THURSDAY, Dec. 25, 2014 (HealthDay News) -- Overeating is common ... you eat in moderation, an expert says. "Don,t arrive ... up calories if you know you,ll be attending a party, ... Jill Ashbey-Pejoves, lead dietitian at Northern Westchester Hospital in Mount ... better to eat healthy during the day and even to ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... , , INCLINE VILLAGE, Nev., ... today reported financial results for the second quarter ended June 30, 2009. ... second quarter of 2009 were $125.9 million, an 18 percent increase from ... primarily to royalty revenues driven by higher product sales of Avastin(R), and ...
... , , , HAYWARD, ... a global leader in the medical aesthetics market, today announced results for ... $27.4 million, an increase of approximately $9.5 million, or 53%, as compared ... the acquisition of Reliant Technologies, Inc. on December 23, 2008. The company ...
... , , , ... GXDX ), a specialized laboratory services provider, today reported revenues of ... $3.7 million benefit from changes in accounting estimates resulting primarily from ... increased 62.8% over revenues of $27.8 million for the comparable period ...
... 30 Nephros, Inc. (OTC Bulletin Board: NEPH), a medical ... infection control, and water purification, today reported that it has ... and warrants to purchase additional common stock for aggregate proceeds ... is pleased to have completed this financing, which was led ...
... , STEWARTVILLE, Minn., July 30 Rochester Medical ... quarter ended June 30, 2009. , , The Company reported ... quarter of last year. The Company also reported net loss of $77,000 ... $312,000 or $.02 per diluted share for the same period of last year. ...
... , , ... GPRO ) today reported financial results for the second ... and record sexually transmitted disease (STD), clinical diagnostics and total product ... the second quarter of 2009 as a good performance from our ...
Cached Medicine News:Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 2Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 3Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 4Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 5Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 6Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 7Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 8Health News:PDL BioPharma Announces Second Quarter 2009 Financial Results 9Health News:Solta Medical Reports Strong Second Quarter 2009 Results 2Health News:Solta Medical Reports Strong Second Quarter 2009 Results 3Health News:Solta Medical Reports Strong Second Quarter 2009 Results 4Health News:Solta Medical Reports Strong Second Quarter 2009 Results 5Health News:Solta Medical Reports Strong Second Quarter 2009 Results 6Health News:Solta Medical Reports Strong Second Quarter 2009 Results 7Health News:Solta Medical Reports Strong Second Quarter 2009 Results 8Health News:Solta Medical Reports Strong Second Quarter 2009 Results 9Health News:Solta Medical Reports Strong Second Quarter 2009 Results 10Health News:Solta Medical Reports Strong Second Quarter 2009 Results 11Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 2Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 3Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 4Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 5Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 6Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 7Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 8Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 9Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 10Health News:Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009 11Health News:Nephros, Inc. Completes $1.25 Million Private Placement 2Health News:Nephros, Inc. Completes $1.25 Million Private Placement 3Health News:Rochester Medical Reports Third Quarter Results 2Health News:Rochester Medical Reports Third Quarter Results 3Health News:Rochester Medical Reports Third Quarter Results 4Health News:Rochester Medical Reports Third Quarter Results 5Health News:Rochester Medical Reports Third Quarter Results 6
(Date:12/24/2014)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... preliminary financial results for the first quarter of ... Ended September 30, 2014 Financial Highlights: , ... in 1Q14 with gross margins improved to 52% ...
(Date:12/24/2014)... SAN DIEGO , Dec. 24, 2014 /PRNewswire/ ... the West, developing the proprietary Natural Killer (NK) ... announces that Dr. Patrick Soon-Shiong , NantWorks ... into a definitive agreement to purchase approximately $48 ... In connection with the investment, he will be ...
(Date:12/24/2014)... 23, 2014 PuraMed BioScience®, Inc., (OTC Pink: ... medicinal and healthcare products, announced it received the initial ... hemp-based, advanced headache relief product, for planned distribution to ... Colorado , Washington State , ... the MigraPure H Advanced headache relief gel formulation completed, ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Sonix CEP provides Emergency Medicine practitioners with high performance imaging in a compact, portable system that boots up in seconds and runs on rechargeable battery up to 30 minutes so it's alwa...
MPatch® is a topical adhesive wound dressing for the local management and control of bleeding from vascular access sites and percutaneous catheters....
O-arm combines the best features of a traditional c-arm with an intra-operative 3D scannerfor unparalleled surgical imaging....
Medicine Products: